| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 74, 1184-1188, Copyright © 1992 by Endocrine Society
ARTICLES |
F Petraglia, TK Woodruff, G Botticelli, A Botticelli, AR Genazzani, KE Mayo and W Vale
Department of Obstetrics and Gynecology, University of Modena, Italy.
The human placenta produces several hypophysiotropic factors that participate in the control of local hormone secretion. In particular, previous reports showed that inhibin and activin modulate both GnRH release and hormonal effect in cultured human placental cells. The present study evaluated the possible correlations among the synthesis and cellular distribution of inhibin, activin, and GnRH in placental villi at term. mRNA coding for inhibin alpha- and beta A-subunits and GnRH were localized in human placenta at term by in situ hybridization using the corresponding cDNA probes. Autoradiograms revealed that some placental cells express inhibin alpha- and beta A-subunit and GnRH mRNAs. A common localization of the three hormonal mRNAs has been found in the inner part of the villi. Using affinity-purified polyclonal antisera, immunocytochemical studies confirmed that in placental villi at term, immunoreactive inhibin alpha- and beta A-subunits and GnRH had a distribution that was superimposable in several areas. Both the outer layer and the inner trophoblasts contained immunoreactive hormonal products. The present data show that some placental cells at term can produce and release inhibin, activin, and/or GnRH. This complement of hypophysiotropic factors may, thus, represent a local paracrine/autocrine control mechanism within the placenta.
This article has been cited by other articles:
![]() |
C.-S. Chou, A. G. Beristain, C. D. MacCalman, and P. C. K. Leung Cellular Localization of Gonadotropin-Releasing Hormone (GnRH) I and GnRH II in First-Trimester Human Placenta and Decidua J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1459 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Arai, K. Tsuchida, K. Uehara, K. Taya, and H. Sugino Characterization of Rat Follistatin-Related Gene: Effects of Estrous Cycle Stage and Pregnancy on Its Messenger RNA Expression in Rat Reproductive Tissues Biol Reprod, January 1, 2003; 68(1): 199 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Moore, D. A. Brown, W. D. Fairlie, A. R. Bauskin, P. K. Brown, M. L. C. Munier, P. K. Russell, L. A. Salamonsen, E. M. Wallace, and S. N. Breit The Transforming Growth Factor-{beta} Superfamily Cytokine Macrophage Inhibitory Cytokine-1 Is Present in High Concentrations in the Serum of Pregnant Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4781 - 4788. [Abstract] [Full Text] |
||||
![]() |
S. C. Riley, R. Leask, C. Balfour, J. E. Brennand, and N. P. Groome Production of inhibin forms by the fetal membranes, decidua, placenta and fetus at parturition Hum. Reprod., March 1, 2000; 15(3): 578 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. CROSS Formation of the Placenta and Extraembryonic Membranes Ann. N.Y. Acad. Sci., October 23, 1998; 857(1): 23 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Petraglia, S. Luisi, C. Benedetto, M. Zonca, P. Florio, E. Casarosa, A. Volpe, S. Bernasconi, and A. R. Genazzani Changes of Dimeric Inhibin B Levels in Maternal Serum Throughout Healthy Gestation and in Women with Gestational Diseases J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2991 - 2995. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Caniggia, S. J. Lye, and J. C. Cross Activin Is a Local Regulator of Human Cytotrophoblast Cell Differentiation Endocrinology, September 1, 1997; 138(9): 3976 - 3986. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Draper, H. Chong, E. Wang, and T. K. Woodruff The Uterine Myometrium Is a Target for Increased Levels of Activin A during Pregnancy Endocrinology, July 1, 1997; 138(7): 3042 - 3046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cross, Z Werb, and S. Fisher Implantation and the placenta: key pieces of the development puzzle Science, December 2, 1994; 266(5190): 1508 - 1518. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |